ArticleJournal of neuro-oncology2026
Incidence of primary central nervous system tumors across age groups and histological groups in Osaka, Japan, 2011-2020.
Article in Journal of neuro-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary central nervous system (CNS) tumors impose a substantial burden of morbidity and mortality globally. Information on the incidence of each histological subtype of primary CNS tumors is limited in Japan. The aim of this study was to describe the incidence of primary CNS tumors across age groups and histological groups in a population-based setting in Osaka, Japan.
methodsPatients diagnosed with primary CNS tumors between 2011 and 2020 were identified using data from the Osaka Cancer Registry. The average annual incidence rate was calculated for 10-year periods. Age-standardized incidence rates were calculated using the 2015 Japan Standard Population, the 2000 US standard population, the 2013 European Standard Population, and the World Standard Population.
resultsA total of 16,650 patients were identified for the overall annual age-standardized incidence rate of 20.81 per 100,000 Japanese standard population (to US standard population, 14.88 per 100,000; to European standard population, 17.98 per 100,000; to world standard population, 12.39 per 100,000). Non-malignant tumors accounted for 72.6% of all tumors. The most common non-malignant and malignant subtypes were meningioma (27.9%) and glioblastoma (13.6%), respectively. Lymphoma was the fifth most common subtype (7.1%). Of malignant tumors, relatively high age-specific incidence rates were found for germ cell tumors in children and lymphoma in older adults.
conclusionsThis study provided a comprehensive description of the incidence of primary CNS tumors in Japan. The results suggest that lymphoma may occupy a major position among primary CNS tumors in Japan when compared with previous reports from other countries.
Indexed as
Identifiers
41838263What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.